Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Sichuan University: Clinical Trials & FDA Approval Profile

Sichuan University (Global / Institutional) sponsors 48 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 25 active protocols (15 recruiting now), 1 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)0.0%
Median Closed Enrollment vs National (145 pts)200 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Sichuan University
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)48
Active Pipeline (Recruiting Now)25 (15)
Completed vs Stopped Early1 / 0 (0.0%)
Median Closed Actual Enrollment200 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Sichuan University
Hospital Research SiteLocationShared Protocols
West China Hospital of Sichuan UniversityChengdu, Sichuan16
West China Hospital,Sichuan UniversityChengdu, Sichuan13
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyWuhan, Hubei2

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Sichuan University
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT06121505Phase II Trial: Low-Dose Radiation + SBRT + Sintilimab + Chemotherapy vs. Sintilimab + Chemotherapy in Locally Advanced or Metastatic SquamoPhase IIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Sichuan University Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI